- Home
- BG vs ICLR Comparison
BG vs ICLR Comparison
Compare BG & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BG
- ICLR
- Stock Information
- Founded
- BG 1818
- ICLR 1990
- Country
- BG United States
- ICLR Ireland
- Employees
- BG N/A
- ICLR N/A
- Industry
- BG Packaged Foods
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- BG Consumer Staples
- ICLR Health Care
- Exchange
- BG Nasdaq
- ICLR Nasdaq
- Market Cap
- BG 10.8B
- ICLR 11.4B
- IPO Year
- BG N/A
- ICLR 1998
- Fundamental
- Price
- BG $81.54
- ICLR $132.49
- Analyst Decision
- BG Buy
- ICLR Buy
- Analyst Count
- BG 5
- ICLR 12
- Target Price
- BG $81.60
- ICLR $204.18
- AVG Volume (30 Days)
- BG 1.7M
- ICLR 2.1M
- Earning Date
- BG 05-07-2025
- ICLR 04-30-2025
- Dividend Yield
- BG 3.44%
- ICLR N/A
- EPS Growth
- BG N/A
- ICLR 11.53
- EPS
- BG 7.82
- ICLR 9.19
- Revenue
- BG $51,334,000,000.00
- ICLR $8,192,621,999.00
- Revenue This Year
- BG $2.71
- ICLR N/A
- Revenue Next Year
- BG $1.95
- ICLR $2.61
- P/E Ratio
- BG $10.42
- ICLR $14.22
- Revenue Growth
- BG N/A
- ICLR N/A
- 52 Week Low
- BG $67.40
- ICLR $133.28
- 52 Week High
- BG $114.92
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- BG 58.64
- ICLR 35.20
- Support Level
- BG $78.10
- ICLR $133.86
- Resistance Level
- BG $83.88
- ICLR $141.21
- Average True Range (ATR)
- BG 2.41
- ICLR 6.57
- MACD
- BG 0.18
- ICLR 0.06
- Stochastic Oscillator
- BG 73.65
- ICLR 8.05
About BG Bunge Limited
Bunge Global SA formerly Bunge Ltd is an agribusiness and food company with operations along the farm-to-consumer food chain. The company segments include Agribusiness; Refined and Specialty Oils; Milling; Sugar and Bioenergy and Corporate and Other. It generates maximum revenue from the Agribusiness segment. The company is an oilseed processor and producer of vegetable oils and protein meals, based on processing capacity, a grain processor, the seller of packaged plant-based oils, producer and seller of wheat flour, bakery mixes and corn-based products in North and South America.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.